<DOC>
	<DOC>NCT02415712</DOC>
	<brief_summary>The objective of this survey is to evaluate the safety and efficacy of fomepizole intravenous infusion in Japanese patients with ethylene glycol and methanol poisonings in daily medical practice.</brief_summary>
	<brief_title>Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance)</brief_title>
	<detailed_description>Clinical studies for fomepizole intravenous infusion have not been conducted in Japan, and there are few reports of data on drug-use, including in the literature, in Japanese patients; therefore, an evaluation of the safety and efficacy of fomepizole intravenous infusion is required. This specified drug-use survey for fomepizole intravenous infusion (Fomepizole Intravenous Infusion 1.5 g "Takeda," hereinafter referred to as "the drug") was planned to evaluate the safety and efficacy of the drug in patients with ethylene glycol and methanol poisoning in daily medical practice.</detailed_description>
	<mesh_term>Poisoning</mesh_term>
	<mesh_term>Fomepizole</mesh_term>
	<criteria>All patients who have been confirmed as receiving the drug</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Pharmacotherapy</keyword>
</DOC>